Cours Merck & Co., Inc. Euronext Paris
Actions
MRK
US58933Y1055
Produits pharmaceutiques
CA 2024 * | 64,18 Md 59,89 Md 57,28 Md | CA 2025 * | 68,68 Md 64,09 Md 61,29 Md | Capitalisation | 328 Md 306 Md 293 Md |
---|---|---|---|---|---|
Résultat net 2024 * | 19,51 Md 18,2 Md 17,41 Md | Résultat net 2025 * | 22,25 Md 20,76 Md 19,86 Md | VE / CA 2024 * | 5,4 x |
Dette nette 2024 * | 18,6 Md 17,36 Md 16,6 Md | Dette nette 2025 * | 7,28 Md 6,79 Md 6,5 Md | VE / CA 2025 * | 4,88 x |
PER 2024 * |
16,7
x | PER 2025 * |
14,5
x | Employés | 71 000 |
Rendement 2024 * |
2,39% | Rendement 2025 * |
2,53% | Flottant | 70,77% |
Dernier transcript sur Merck & Co., Inc.
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Robert Davis
CEO | Chief Executive Officer | 57 | 01/04/14 |
Director of Finance/CFO | 55 | 01/01/90 | |
Dave Williams
CTO | Chief Tech/Sci/R&D Officer | 55 | 01/08/20 |
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Tom Glocer
BRD | Director/Board Member | 63 | 27/11/07 |
Pamela Craig
BRD | Director/Board Member | 67 | 01/09/15 |
Inge Thulin
BRD | Director/Board Member | 69 | 01/03/18 |
Nom | PEA | Position | Varia. 1 janv. | Notation |
---|---|---|---|---|
BRANDES US VALUE I USD ACC | Non | 29.03M USD | +6,00% | |
AMUNDI ACTIONS USA ISR P C | Non | 25.82M EUR | +14,00% | |
BGF WORLD HEALTHSCIENCE A2 | Non | 525.58M USD | -2,00% | |
AXAWF II NORTH AMERICAN EQS A DIS USD | Non | 3.77M USD | +15,00% | |
BELFIUS EQUITIES GLOB HEALTH CARE C$ CAP | Non | 23M USD | -3,00% |
Varia. 1 janv. | Capi. | |
---|---|---|
+50,70% | 791 Md | |
+41,50% | 630 Md | |
+8,79% | 298 Md | |
+17,57% | 246 Md | |
+0,20% | 225 Md | |
+9,92% | 218 Md | |
+3,68% | 160 Md | |
-4,38% | 156 Md | |
-3,33% | 116 Md |